Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure or medication that can reverse or stop the progression of PPA. The ...

Primary progressive aphasia is a neurological condition that causes a gradual decline in language abilities. There is no cure ...

University of Arizona scientists have developed a promising new treatment for aphasia, a neurological language disorder.

The inspiring 13-year-old cancer patient is bringing joy and smiles to the Michael Rice Centre with his TikTok dance routines which have roped in nurses, his oncologist, music therapist ...

A patient sustained minor injuries after a fire broke out April 7 in a patient room at UPMC Hanover (Pa.), a UPMC spokesperson confirmed in a statement shared with Becker’s.

Multiple failings led to a patient with Crohn's disease having a hysterectomy without giving informed consent, an ombudsman has found. The woman, in her early 40s, said it has left her feeling ...

Concerns over negligence at the Ermelo Provincial Hospital have surfaced after a high-risk psychiatric patient disappeared from the hospital, was found, readmitted and then attempted suicide ...

“It definitely makes it easier for providers [to counsel patients]," says Landon Trost, MD. With the FDA’s recent class-wide labeling changes for testosterone products 1, urologist Landon Trost, MD, ...

The B.C. government announced on Monday it is ending the program that sent some patients to the U.S. for radiation therapy. The program, which began in May 2023, offered eligible patients the ...

reducing quality of life and increasing suffering for both patients and families," Jason Krellman, a clinical neuropsychologist and assistant professor at Columbia University Irving Medical Center ...

Dual-eligible or Medicaid patients followed closely at nearly 16%. Those with Veterans Affairs coverage reported the highest portal usage but were among the least likely to face a copay.

“Patients will end up paying for these products,” Richard Saynor, chief executive officer of Sandoz AG, Europe’s largest generic drug maker, said last month. “Either supply will get worse and/or the ...